This report provides a comprehensive analysis of the global Ex Vivo Skin Explants market, tracking its projected growth through 2032. It examines the industry's evolution across human and animal tissue types, focusing on critical applications in the pharmaceutical and cosmetic sectors. By evaluating key regional markets including the United States, China, and Europe, the study highlights essential trends, competitive landscapes, and strategic maneuvers by leading players such as Genoskin and MatTek Life Sciences.

Market Overview

The global Ex Vivo Skin Explants market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate throughout the forecast period.

Product Definition and Utility

Ex Vivo Skin Explants are pieces of skin tissue that have been surgically removed from a living organism (human or animal) and maintained outside the body for research purposes.

• Biological Value: These explants retain the natural architecture and cellular composition of the original tissue, making them valuable for studying various aspects of skin biology, pharmacology, toxicology, and disease mechanisms.
• Research Applications: Ex vivo skin explants are used to evaluate the effects of drugs, chemicals, and biological agents on skin responses, providing insights into both normal and pathological skin conditions.

Regional Market Outlook

• United States: The market for Ex Vivo Skin Explants in the United States is estimated to increase over the period from 2025 to 2032, growing at a consistent compound annual growth rate.
• China: The market for Ex Vivo Skin Explants in China is estimated to increase over the period from 2025 to 2032, growing at a consistent compound annual growth rate.
• Europe: The market for Ex Vivo Skin Explants in Europe is estimated to increase over the period from 2025 to 2032, growing at a consistent compound annual growth rate.

Market Segmentation

By Type

• Human Skin Explants
• Animal Skin Explants

By Application

• Pharmaceutical
• Cosmetic
• Others

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Market Dynamics

• Market Concentration: In terms of revenue, the global two largest companies occupied a significant portion of the market share in 2025.
• Strategic Analysis: This report analyzes the strategies of leading global companies, focusing on their Ex Vivo Skin Explants portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positions in an accelerating market.
• Industry Trends: The report highlights key trends related to product segmentation, company formation, revenue, market share, latest developments, and M&A activity.

Key Players

The following companies have been profiled based on primary expert input and analysis of their coverage, product portfolio, and market penetration:

• Genoskin
• MatTek Life Sciences
• Creative Bioarray
• EpiSkin
• Reprocell
• Alcyomics
• Epistem
• QIMA Life Sciences
• Extherid Biosciences
• Perfectus Biomed
• Xenometrix
• Syntivia
• Creative Biolabs

Report Scope and Methodology

LPI (LP Information)'s newest research report, the “Ex Vivo Skin Explants Industry Forecast,” provides a comprehensive analysis of the global Ex Vivo Skin Explants landscape.

• Content Scope: The report reviews total world Ex Vivo Skin Explants sales in 2025 and provides a detailed analysis in US$ millions of projected sales for 2026 through 2032, broken down by region, market sector, and sub-sector.
• Analytical Depth: The study evaluates key market trends, drivers, and affecting factors shaping the global outlook. It provides a comprehensive overview of market shares and growth opportunities by product type, application, key players, and key regions/countries.
• Methodology: Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory of the global Ex Vivo Skin Explants industry, highlighting emerging pockets of opportunity.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Ex Vivo Skin Explants Market Size (2021-2032)

    • 2.1.2 Ex Vivo Skin Explants Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Ex Vivo Skin Explants by Country/Region (2021, 2025 & 2032)

  • 2.2 Ex Vivo Skin Explants Segment by Type

    • 2.2.1 Human Skin Explants

    • 2.2.2 Animal Skin Explants

    • 2.2.3 Ex Vivo Skin Explants Market Size by Type

      • 2.2.3.1 Ex Vivo Skin Explants Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.3.2 Global Ex Vivo Skin Explants Market Size Market Share by Type (2021-2026)

  • 2.3 Ex Vivo Skin Explants Segment by Application

    • 2.3.1 Pharmaceutical

    • 2.3.2 Cosmetic

    • 2.3.3 Others

    • 2.3.4 Ex Vivo Skin Explants Market Size by Application

      • 2.3.4.1 Ex Vivo Skin Explants Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.4.2 Global Ex Vivo Skin Explants Market Size Market Share by Application (2021-2026)

• 3 Ex Vivo Skin Explants Market Size by Player

  • 3.1 Ex Vivo Skin Explants Market Size Market Share by Player

    • 3.1.1 Global Ex Vivo Skin Explants Revenue by Player (2021-2026)

    • 3.1.2 Global Ex Vivo Skin Explants Revenue Market Share by Player (2021-2026)

  • 3.2 Global Ex Vivo Skin Explants Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Ex Vivo Skin Explants by Region

  • 4.1 Ex Vivo Skin Explants Market Size by Region (2021-2026)

  • 4.2 Global Ex Vivo Skin Explants Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Ex Vivo Skin Explants Market Size Growth (2021-2026)

  • 4.4 APAC Ex Vivo Skin Explants Market Size Growth (2021-2026)

  • 4.5 Europe Ex Vivo Skin Explants Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Ex Vivo Skin Explants Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Ex Vivo Skin Explants Market Size by Country (2021-2026)

  • 5.2 Americas Ex Vivo Skin Explants Market Size by Type (2021-2026)

  • 5.3 Americas Ex Vivo Skin Explants Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Ex Vivo Skin Explants Market Size by Region (2021-2026)

  • 6.2 APAC Ex Vivo Skin Explants Market Size by Type (2021-2026)

  • 6.3 APAC Ex Vivo Skin Explants Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Ex Vivo Skin Explants Market Size by Country (2021-2026)

  • 7.2 Europe Ex Vivo Skin Explants Market Size by Type (2021-2026)

  • 7.3 Europe Ex Vivo Skin Explants Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Ex Vivo Skin Explants by Region (2021-2026)

  • 8.2 Middle East & Africa Ex Vivo Skin Explants Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Ex Vivo Skin Explants Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Ex Vivo Skin Explants Market Forecast

  • 10.1 Global Ex Vivo Skin Explants Forecast by Region (2027-2032)

    • 10.1.1 Global Ex Vivo Skin Explants Forecast by Region (2027-2032)

    • 10.1.2 Americas Ex Vivo Skin Explants Forecast

    • 10.1.3 APAC Ex Vivo Skin Explants Forecast

    • 10.1.4 Europe Ex Vivo Skin Explants Forecast

    • 10.1.5 Middle East & Africa Ex Vivo Skin Explants Forecast

  • 10.2 Americas Ex Vivo Skin Explants Forecast by Country (2027-2032)

    • 10.2.1 United States Market Ex Vivo Skin Explants Forecast

    • 10.2.2 Canada Market Ex Vivo Skin Explants Forecast

    • 10.2.3 Mexico Market Ex Vivo Skin Explants Forecast

    • 10.2.4 Brazil Market Ex Vivo Skin Explants Forecast

  • 10.3 APAC Ex Vivo Skin Explants Forecast by Region (2027-2032)

    • 10.3.1 China Ex Vivo Skin Explants Market Forecast

    • 10.3.2 Japan Market Ex Vivo Skin Explants Forecast

    • 10.3.3 Korea Market Ex Vivo Skin Explants Forecast

    • 10.3.4 Southeast Asia Market Ex Vivo Skin Explants Forecast

    • 10.3.5 India Market Ex Vivo Skin Explants Forecast

    • 10.3.6 Australia Market Ex Vivo Skin Explants Forecast

  • 10.4 Europe Ex Vivo Skin Explants Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Ex Vivo Skin Explants Forecast

    • 10.4.2 France Market Ex Vivo Skin Explants Forecast

    • 10.4.3 UK Market Ex Vivo Skin Explants Forecast

    • 10.4.4 Italy Market Ex Vivo Skin Explants Forecast

    • 10.4.5 Russia Market Ex Vivo Skin Explants Forecast

  • 10.5 Middle East & Africa Ex Vivo Skin Explants Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Ex Vivo Skin Explants Forecast

    • 10.5.2 South Africa Market Ex Vivo Skin Explants Forecast

    • 10.5.3 Israel Market Ex Vivo Skin Explants Forecast

    • 10.5.4 Turkey Market Ex Vivo Skin Explants Forecast

  • 10.6 Global Ex Vivo Skin Explants Forecast by Type (2027-2032)

  • 10.7 Global Ex Vivo Skin Explants Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Ex Vivo Skin Explants Forecast

• 11 Key Players Analysis

  • 11.1 Genoskin

    • 11.1.1 Genoskin Company Information

    • 11.1.2 Genoskin Ex Vivo Skin Explants Product Offered

    • 11.1.3 Genoskin Ex Vivo Skin Explants Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Genoskin Main Business Overview

    • 11.1.5 Genoskin Latest Developments

  • 11.2 MatTek Life Sciences

    • 11.2.1 MatTek Life Sciences Company Information

    • 11.2.2 MatTek Life Sciences Ex Vivo Skin Explants Product Offered

    • 11.2.3 MatTek Life Sciences Ex Vivo Skin Explants Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 MatTek Life Sciences Main Business Overview

    • 11.2.5 MatTek Life Sciences Latest Developments

  • 11.3 Creative Bioarray

    • 11.3.1 Creative Bioarray Company Information

    • 11.3.2 Creative Bioarray Ex Vivo Skin Explants Product Offered

    • 11.3.3 Creative Bioarray Ex Vivo Skin Explants Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Creative Bioarray Main Business Overview

    • 11.3.5 Creative Bioarray Latest Developments

  • 11.4 EpiSkin

    • 11.4.1 EpiSkin Company Information

    • 11.4.2 EpiSkin Ex Vivo Skin Explants Product Offered

    • 11.4.3 EpiSkin Ex Vivo Skin Explants Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 EpiSkin Main Business Overview

    • 11.4.5 EpiSkin Latest Developments

  • 11.5 Reprocell

    • 11.5.1 Reprocell Company Information

    • 11.5.2 Reprocell Ex Vivo Skin Explants Product Offered

    • 11.5.3 Reprocell Ex Vivo Skin Explants Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Reprocell Main Business Overview

    • 11.5.5 Reprocell Latest Developments

  • 11.6 Alcyomics

    • 11.6.1 Alcyomics Company Information

    • 11.6.2 Alcyomics Ex Vivo Skin Explants Product Offered

    • 11.6.3 Alcyomics Ex Vivo Skin Explants Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Alcyomics Main Business Overview

    • 11.6.5 Alcyomics Latest Developments

  • 11.7 Epistem

    • 11.7.1 Epistem Company Information

    • 11.7.2 Epistem Ex Vivo Skin Explants Product Offered

    • 11.7.3 Epistem Ex Vivo Skin Explants Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Epistem Main Business Overview

    • 11.7.5 Epistem Latest Developments

  • 11.8 QIMA Life Sciences

    • 11.8.1 QIMA Life Sciences Company Information

    • 11.8.2 QIMA Life Sciences Ex Vivo Skin Explants Product Offered

    • 11.8.3 QIMA Life Sciences Ex Vivo Skin Explants Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 QIMA Life Sciences Main Business Overview

    • 11.8.5 QIMA Life Sciences Latest Developments

  • 11.9 Extherid Biosciences

    • 11.9.1 Extherid Biosciences Company Information

    • 11.9.2 Extherid Biosciences Ex Vivo Skin Explants Product Offered

    • 11.9.3 Extherid Biosciences Ex Vivo Skin Explants Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Extherid Biosciences Main Business Overview

    • 11.9.5 Extherid Biosciences Latest Developments

  • 11.10 Perfectus Biomed

    • 11.10.1 Perfectus Biomed Company Information

    • 11.10.2 Perfectus Biomed Ex Vivo Skin Explants Product Offered

    • 11.10.3 Perfectus Biomed Ex Vivo Skin Explants Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Perfectus Biomed Main Business Overview

    • 11.10.5 Perfectus Biomed Latest Developments

  • 11.11 Xenometrix

    • 11.11.1 Xenometrix Company Information

    • 11.11.2 Xenometrix Ex Vivo Skin Explants Product Offered

    • 11.11.3 Xenometrix Ex Vivo Skin Explants Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Xenometrix Main Business Overview

    • 11.11.5 Xenometrix Latest Developments

  • 11.12 Syntivia

    • 11.12.1 Syntivia Company Information

    • 11.12.2 Syntivia Ex Vivo Skin Explants Product Offered

    • 11.12.3 Syntivia Ex Vivo Skin Explants Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Syntivia Main Business Overview

    • 11.12.5 Syntivia Latest Developments

  • 11.13 Creative Biolabs

    • 11.13.1 Creative Biolabs Company Information

    • 11.13.2 Creative Biolabs Ex Vivo Skin Explants Product Offered

    • 11.13.3 Creative Biolabs Ex Vivo Skin Explants Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Creative Biolabs Main Business Overview

    • 11.13.5 Creative Biolabs Latest Developments

• 12 Research Findings and Conclusion